MicroRNA‐21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2‐positive metastatic breast cancer-Reference-Cited by-同舟云学术

MicroRNA‐21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2‐positive metastatic breast cancer

Published:2018-09-23 Issue:3 Volume:120 Page:3459-3466
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Badr Marwa¹,Said Hebatallah¹,Louka Manal L.¹^ORCID,Elghazaly Hesham A.²,Gaballah Ahmed²,Atef Abd El Mageed Mai²

Affiliation:

1. Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine Ain Shams University Cairo Egypt

2. Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine Ain Shams University Cairo Egypt

Funder

Ain Shams University, Faculty of medicine

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27620

Reference29 articles.

1. 2017 American Cancer Society American Cancer Society Breast cancer

2. 2018 National Cancer Institute of the USA National Cancer Institute of the USA Cancer statistics

3. Breast cancer chapter;Ferri's Clinical Advisor,2018

4. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring

5. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review);Molecular Medicine Reports;2023-10-25

2. MicroRNA based combinatorial therapy against TKIs resistant CML by inactivating the PI3K/Akt/mTOR pathway: a review;Medical Oncology;2023-09-15

3. Plasma microRNA-195, −34c, and − 1246 as novel biomarkers for the diagnosis of trastuzumab-resistant HER2-positive breast cancer patients;Toxicology and Applied Pharmacology;2023-09

4. microRNAs signature in relapse metastasis and de novo metastasis of breast cancer. A systematic review;Critical Reviews in Oncology/Hematology;2023-08

5. In situ detection of exosomal RNAs for cancer diagnosis;Acta Biomaterialia;2023-01